Selected research
Industry Research
Diltiazem Hydrochloride Injection Industry Research Report 2026
Market perspective
The global Diltiazem Hydrochloride Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diltiazem Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diltiazem Hydrochloride Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diltiazem Hydrochloride Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diltiazem Hydrochloride Injection include Zhejiang Yatai Pharmaceutical, Shanghai Pharmaceuticals, SHANDONG FANGMING BANGJIA PHARMACEUTICAL, Mylan Pharmaceuticals, JiangSu WuZhong Pharmaceutical, Pfizer, Torrent Pharmaceuticals, SGPharma and SagentPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diltiazem Hydrochloride Injection market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diltiazem Hydrochloride Injection Market by Company
Zhejiang Yatai Pharmaceutical
Shanghai Pharmaceuticals
SHANDONG FANGMING BANGJIA PHARMACEUTICAL
Mylan Pharmaceuticals
JiangSu WuZhong Pharmaceutical
Pfizer
Torrent Pharmaceuticals
SGPharma
SagentPharma
Nova Plus Pharmaceuticals
Hikma Pharmaceuticals
Eugia US
AdvaCare Pharma
Diltiazem Hydrochloride Injection Segment by Type
10mg/1ml
10mg/2ml
Diltiazem Hydrochloride Injection Segment by Application
Cardiovascular System Diseases
Surgery-Related Applications
Diltiazem Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diltiazem Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diltiazem Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diltiazem Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diltiazem Hydrochloride Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diltiazem Hydrochloride Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diltiazem Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/1ml
- 10mg/2ml
Applications
- Cardiovascular System Diseases
- Surgery-Related Applications
Companies covered
- Zhejiang Yatai Pharmaceutical
- Shanghai Pharmaceuticals
- SHANDONG FANGMING BANGJIA PHARMACEUTICAL
- Mylan Pharmaceuticals
- JiangSu WuZhong Pharmaceutical
- Pfizer
- Torrent Pharmaceuticals
- SGPharma
- SagentPharma
- Nova Plus Pharmaceuticals
- Hikma Pharmaceuticals
- Eugia US
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diltiazem Hydrochloride Injection Market Size (2021-2032)
- 2.2.2 Global Diltiazem Hydrochloride Injection Sales (2021-2032)
- 2.2.3 Global Diltiazem Hydrochloride Injection Market Average Price (2021-2032)
- 2.3 Diltiazem Hydrochloride Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg/1ml
- 2.3.3 10mg/2ml
- 2.4 Diltiazem Hydrochloride Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cardiovascular System Diseases
- 2.4.3 Surgery-Related Applications
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diltiazem Hydrochloride Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diltiazem Hydrochloride Injection Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Diltiazem Hydrochloride Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Diltiazem Hydrochloride Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Diltiazem Hydrochloride Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diltiazem Hydrochloride Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diltiazem Hydrochloride Injection, Product Type & Application
- 3.8 Global Manufacturers of Diltiazem Hydrochloride Injection, Established Date
- 3.9 Global Diltiazem Hydrochloride Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zhejiang Yatai Pharmaceutical
- 4.1.1 Zhejiang Yatai Pharmaceutical Company Information
- 4.1.2 Zhejiang Yatai Pharmaceutical Business Overview
- 4.1.3 Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zhejiang Yatai Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio
- 4.1.5 Zhejiang Yatai Pharmaceutical Recent Developments
- 4.2 Shanghai Pharmaceuticals
- 4.2.1 Shanghai Pharmaceuticals Company Information
- 4.2.2 Shanghai Pharmaceuticals Business Overview
- 4.2.3 Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
- 4.2.5 Shanghai Pharmaceuticals Recent Developments
- 4.3 SHANDONG FANGMING BANGJIA PHARMACEUTICAL
- 4.3.1 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Company Information
- 4.3.2 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Business Overview
- 4.3.3 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Diltiazem Hydrochloride Injection Product Portfolio
- 4.3.5 SHANDONG FANGMING BANGJIA PHARMACEUTICAL Recent Developments
- 4.4 Mylan Pharmaceuticals
- 4.4.1 Mylan Pharmaceuticals Company Information
- 4.4.2 Mylan Pharmaceuticals Business Overview
- 4.4.3 Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
- 4.4.5 Mylan Pharmaceuticals Recent Developments
- 4.5 JiangSu WuZhong Pharmaceutical
- 4.5.1 JiangSu WuZhong Pharmaceutical Company Information
- 4.5.2 JiangSu WuZhong Pharmaceutical Business Overview
- 4.5.3 JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 JiangSu WuZhong Pharmaceutical Diltiazem Hydrochloride Injection Product Portfolio
- 4.5.5 JiangSu WuZhong Pharmaceutical Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Diltiazem Hydrochloride Injection Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Torrent Pharmaceuticals
- 4.7.1 Torrent Pharmaceuticals Company Information
- 4.7.2 Torrent Pharmaceuticals Business Overview
- 4.7.3 Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Torrent Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
- 4.7.5 Torrent Pharmaceuticals Recent Developments
- 4.8 SGPharma
- 4.8.1 SGPharma Company Information
- 4.8.2 SGPharma Business Overview
- 4.8.3 SGPharma Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SGPharma Diltiazem Hydrochloride Injection Product Portfolio
- 4.8.5 SGPharma Recent Developments
- 4.9 SagentPharma
- 4.9.1 SagentPharma Company Information
- 4.9.2 SagentPharma Business Overview
- 4.9.3 SagentPharma Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SagentPharma Diltiazem Hydrochloride Injection Product Portfolio
- 4.9.5 SagentPharma Recent Developments
- 4.10 Nova Plus Pharmaceuticals
- 4.10.1 Nova Plus Pharmaceuticals Company Information
- 4.10.2 Nova Plus Pharmaceuticals Business Overview
- 4.10.3 Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nova Plus Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
- 4.10.5 Nova Plus Pharmaceuticals Recent Developments
- 4.11 Hikma Pharmaceuticals
- 4.11.1 Hikma Pharmaceuticals Company Information
- 4.11.2 Hikma Pharmaceuticals Business Overview
- 4.11.3 Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hikma Pharmaceuticals Diltiazem Hydrochloride Injection Product Portfolio
- 4.11.5 Hikma Pharmaceuticals Recent Developments
- 4.12 Eugia US
- 4.12.1 Eugia US Company Information
- 4.12.2 Eugia US Business Overview
- 4.12.3 Eugia US Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Eugia US Diltiazem Hydrochloride Injection Product Portfolio
- 4.12.5 Eugia US Recent Developments
- 4.13 AdvaCare Pharma
- 4.13.1 AdvaCare Pharma Company Information
- 4.13.2 AdvaCare Pharma Business Overview
- 4.13.3 AdvaCare Pharma Diltiazem Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AdvaCare Pharma Diltiazem Hydrochloride Injection Product Portfolio
- 4.13.5 AdvaCare Pharma Recent Developments
5 Global Diltiazem Hydrochloride Injection Market Scenario by Region
- 5.1 Global Diltiazem Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diltiazem Hydrochloride Injection Sales by Region: 2021-2032
- 5.2.1 Global Diltiazem Hydrochloride Injection Sales by Region: 2021-2026
- 5.2.2 Global Diltiazem Hydrochloride Injection Sales by Region: 2027-2032
- 5.3 Global Diltiazem Hydrochloride Injection Revenue by Region: 2021-2032
- 5.3.1 Global Diltiazem Hydrochloride Injection Revenue by Region: 2021-2026
- 5.3.2 Global Diltiazem Hydrochloride Injection Revenue by Region: 2027-2032
- 5.4 North America Diltiazem Hydrochloride Injection Market Facts & Figures by Country
- 5.4.1 North America Diltiazem Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
- 5.4.3 North America Diltiazem Hydrochloride Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diltiazem Hydrochloride Injection Market Facts & Figures by Country
- 5.5.1 Europe Diltiazem Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
- 5.5.3 Europe Diltiazem Hydrochloride Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diltiazem Hydrochloride Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diltiazem Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diltiazem Hydrochloride Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diltiazem Hydrochloride Injection Market Facts & Figures by Country
- 5.7.1 South America Diltiazem Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
- 5.7.3 South America Diltiazem Hydrochloride Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Diltiazem Hydrochloride Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diltiazem Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diltiazem Hydrochloride Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diltiazem Hydrochloride Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diltiazem Hydrochloride Injection Sales by Type (2021-2032)
- 6.1.1 Global Diltiazem Hydrochloride Injection Sales by Type (2021-2032) & (L)
- 6.1.2 Global Diltiazem Hydrochloride Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Diltiazem Hydrochloride Injection Revenue by Type (2021-2032)
- 6.2.1 Global Diltiazem Hydrochloride Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diltiazem Hydrochloride Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Diltiazem Hydrochloride Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diltiazem Hydrochloride Injection Sales by Application (2021-2032)
- 7.1.1 Global Diltiazem Hydrochloride Injection Sales by Application (2021-2032) & (L)
- 7.1.2 Global Diltiazem Hydrochloride Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Diltiazem Hydrochloride Injection Revenue by Application (2021-2032)
- 7.2.1 Global Diltiazem Hydrochloride Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diltiazem Hydrochloride Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Diltiazem Hydrochloride Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diltiazem Hydrochloride Injection Value Chain Analysis
- 8.1.1 Diltiazem Hydrochloride Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diltiazem Hydrochloride Injection Production Mode & Process
- 8.2 Diltiazem Hydrochloride Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diltiazem Hydrochloride Injection Distributors
- 8.2.3 Diltiazem Hydrochloride Injection Customers
9 Global Diltiazem Hydrochloride Injection Analyzing Market Dynamics
- 9.1 Diltiazem Hydrochloride Injection Industry Trends
- 9.2 Diltiazem Hydrochloride Injection Industry Drivers
- 9.3 Diltiazem Hydrochloride Injection Industry Opportunities and Challenges
- 9.4 Diltiazem Hydrochloride Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst